publication date: Apr. 12, 2019

Conversation with The Cancer Letter

Fred Hirsch: New center focuses Mount Sinai’s thoracic oncology programs

Fred R. Hirsch

Fred R. Hirsch

Executive director,

Center for Thoracic Oncology, Mount Sinai


Every year, 800 to 1,000 new patients get referred to The Tisch Cancer Insitute of Mount Sinai lung cancer specialists.

“It is huge here in America, and it is one of the largest numbers. I don’t have from top of my head the numbers of other areas, but I wouldn’t be surprised if this is a top number in United States,” said Fred R. Hirsch, executive director of the newly-created Center for Thoracic Oncology at Mount Sinai.

Hirsch came to Mount Sinai from the University of Colorado School of Medicine in Denver, where he was the associate director for the University of Colorado Cancer Center and a professor of medicine and pathology. While in Colorado, Hirsch was the CEO of the International Association for the Study of Lung Cancer, a global organization dedicated solely to the study of lung cancer and other thoracic malignancies.

“Mount Sinai made the decision to make a significant investment in lung cancer, thoracic malignancies, and the started a new center of excellence for thoracic oncology within the Tisch Cancer Institute, which did not exist before,” Hirsch said to The Cancer Letter. “So, that was an opportunity.”

Hirsch was also named the Richard Stein, Joe Lowe, and Louis Price … Continue reading Fred Hirsch: New center focuses Mount Sinai’s thoracic oncology programs

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.